Phase 2 Open-Label Extension Study (OLE) of Patisiran, an Investigational RNAi Therapeutic for Familial Amyloid Polyneuropathy (FAP) (S38.003)
暂无分享,去创建一个
B. Bettencourt | K. Gruis | J. Gollob | H. Schmidt | I. Conceição | R. Falzone | J. Cehelsky | S. Nochur | A. Vaishnaw | D. Adams | J. Berk | J. Campistol | J. Buades | M. Waddington‐Cruz | T. Coelho | O. Suhr | J. Pouget | Lindsey White | M. Waddington-Cruz | H. Schmidt